Lee, Y. J., Kim, W., Hong, S., Lee, Y. J., Lee, J., Kim, S. W., . . . Nam, E. J. (2024). The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation. Journal of gynecologic oncology, 35(6), e80-12. https://doi.org/10.3802/jgo.2024.35.e80
Chicago Style (17th ed.) CitationLee, Young Joo, Woojin Kim, Soomin Hong, Yong Jae Lee, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, and Eun Ji Nam. "The Effectiveness of CA125 and HE4 as Clinical Prognostic Markers in Epithelial Ovarian Cancer Patients with BRCA Mutation." Journal of Gynecologic Oncology 35, no. 6 (2024): e80-12. https://doi.org/10.3802/jgo.2024.35.e80.
MLA (9th ed.) CitationLee, Young Joo, et al. "The Effectiveness of CA125 and HE4 as Clinical Prognostic Markers in Epithelial Ovarian Cancer Patients with BRCA Mutation." Journal of Gynecologic Oncology, vol. 35, no. 6, 2024, pp. e80-12, https://doi.org/10.3802/jgo.2024.35.e80.